33 related articles for article (PubMed ID: 19282655)
1. TRAIL induces proliferation of human glioma cells by c-FLIPL-mediated activation of ERK1/2.
Vilimanovich U; Bumbasirevic V
Cell Mol Life Sci; 2008 Mar; 65(5):814-26. PubMed ID: 18239851
[TBL] [Abstract][Full Text] [Related]
2. c-FLIP, a master anti-apoptotic regulator.
Safa AR
Exp Oncol; 2012 Oct; 34(3):176-84. PubMed ID: 23070002
[TBL] [Abstract][Full Text] [Related]
3. YM155 sensitizes HeLa cells to TRAIL-mediated apoptosis via cFLIP and survivin downregulation.
Chandrasekaran AP; Poondla N; Ko NR; Oh SJ; Ramakrishna S
Oncol Lett; 2020 Oct; 20(4):72. PubMed ID: 32863905
[TBL] [Abstract][Full Text] [Related]
4. miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.
Zong H; Zhou H; Xiang Y; Wu G
Oncol Lett; 2019 Dec; 18(6):6822-6828. PubMed ID: 31788125
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-induced variation of cell signaling states provides nonheritable resistance to apoptosis.
Baskar R; Fienberg HG; Khair Z; Favaro P; Kimmey S; Green DR; Nolan GP; Plevritis S; Bendall SC
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31704709
[TBL] [Abstract][Full Text] [Related]
6. TRAILblazing Strategies for Cancer Treatment.
Kretz AL; Trauzold A; Hillenbrand A; Knippschild U; Henne-Bruns D; von Karstedt S; Lemke J
Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30935038
[TBL] [Abstract][Full Text] [Related]
7. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
Li M; An W; Xu L; Lin Y; Su L; Liu X
J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
[TBL] [Abstract][Full Text] [Related]
8. Lesser-Known Molecules in Ovarian Carcinogenesis.
Lozneanu L; Cojocaru E; Giuşcă SE; Cărăuleanu A; Căruntu ID
Biomed Res Int; 2015; 2015():321740. PubMed ID: 26339605
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of cellular FLICE-inhibitory protein (Long Form) contributes to apoptosis induced by Hsp90 inhibition in human lung cancer cells.
Wang Q; Sun W; Hao X; Li T; Su L; Liu X
Cancer Cell Int; 2012 Dec; 12(1):54. PubMed ID: 23256568
[TBL] [Abstract][Full Text] [Related]
10. Molecular biology of gallbladder cancer: potential clinical implications.
Andrén-Sandberg A
N Am J Med Sci; 2012 Oct; 4(10):435-41. PubMed ID: 23112962
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFα-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein.
Scudiero I; Zotti T; Ferravante A; Vessichelli M; Reale C; Masone MC; Leonardi A; Vito P; Stilo R
J Biol Chem; 2012 Feb; 287(8):6053-61. PubMed ID: 22219201
[TBL] [Abstract][Full Text] [Related]
12. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
[TBL] [Abstract][Full Text] [Related]
14. Targeting c-FLIP in cancer.
Shirley S; Micheau O
Cancer Lett; 2013 May; 332(2):141-50. PubMed ID: 21071136
[TBL] [Abstract][Full Text] [Related]
15. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy.
Safa AR; Day TW; Wu CH
Curr Cancer Drug Targets; 2008 Feb; 8(1):37-46. PubMed ID: 18288942
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of c-FLIP confers the resistance to TRAIL-induced apoptosis on gallbladder carcinoma.
Zong H; Yin B; Chen J; Ma B; Cai D; He X
Tohoku J Exp Med; 2009 Mar; 217(3):203-8. PubMed ID: 19282655
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
